Skip to main content
Log in

Controlling Scabies in Institutional Settings

A Review of Medications, Treatment Models, and Implementation

  • Therapy in Practice
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Scabies is a global problem and a significant source of morbidity in nursing home residents and workers because of its highly contagious nature. It is also a problem in hospitals that care for the elderly, the debilitated, and the immunocompromised. New outbreaks continue to occur, despite controlling the recurrent epidemics. Scabies manifests as papules, pustules, burrows, nodules, and occasionally urticarial papules and plaques. Most of the patients with scabies experience severe pruritus. A subset of patients have crusted or Norwegian scabies. These patients, who are usually debilitated or immunocompromised, do not experience the urge to scratch, and therefore do not scratch their own skin. Diagnosis of scabies is based on patient history, physical examination, and demonstration of mites, eggs, or scybala (black or brown football-shaped masses of feces of scabies) on microscopic examination.

Scabies can be treated with topical or oral therapies. Topical treatments include 5% permethrin cream, 1% lindane (gamma benzene hexachloride) lotion, 6% precipitated sulfur in petrolatum, crotamiton, malathion, allethrin spray, and benzyl benzoate. Ivermectin, the only oral treatment, is not approved for scabies in the US. Most authorities advocate using a scabicide several times, specifically once a week over a period of 2–3 weeks. In an outbreak of scabies in a nursing home, residents, staff, and frequent visitors should all be treated even if they are not symptomatic. Ivermectin is useful in treating patients with Norwegian or crusted scabies, or who are debilitated. Ivermectin has no serious reported adverse effects. Model treatment plans to stop scabies epidemics have been developed. These plans coordinate treatment of all persons exposed (including ivermectin for debilitated patients), isolation of infected patients, disinfection of objects that patients have come into contact with, and education and reassurance of the medical staff. Failure to coordinate notification, education, treatment, and disinfection leads to failure to control scabies epidemics. Control of epidemics of institutional scabies requires attention to treatment effects and logistics. Treatment is low risk, but cumbersome because many individuals need be treated. It is advisable to restrict, where possible, the number of staff members that deal with scabies patients to limit the spread of the scabies. Prolonged surveillance is required for the eradication of institutional scabies. While the foregoing plans require coordination of all involved personnel and sustained efforts, they are necessary to halt the spread of scabies to patients and staff, to enhance their morale, and to prevent deterioration of labor and public relations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Table I
Table II

Similar content being viewed by others

References

  1. Problems in nursing homes for the aged. Scabies returns: massively! Krankenpfl J 2002; 40 (1–2): 38–9

    Google Scholar 

  2. Tan HH, Goh CL. Parasitic skin infections in the elderly: recognition and drug treatment. Drugs Aging 2001; 18 (3): 165–76

    Article  PubMed  CAS  Google Scholar 

  3. Chouela E, Abeldano A, Pellerano G, et al. Diagnosis and treatment of scabies: a practical guide. Am J Clin Dermatol 2002; 3: 9–18

    Article  PubMed  Google Scholar 

  4. Haag ML, Brozena SJ, Fenske NA. Attack of the scabies: what to do when an outbreak occurs. Geriatrics 1993; 48: 45–6, 51–3

    PubMed  CAS  Google Scholar 

  5. Levine N. Scaly, crusted papules: these pruritic lesions can become epidemic in nursing home residents [letter]. Geriatrics 1997; 52: 90

    PubMed  CAS  Google Scholar 

  6. Moberg SA, Lowhagen GB, Hersle KS. An epidemic of scabies with unusual features and treatment resistance in a nursing home. J Am Acad Dermatol 1984; 11: 242–4

    Article  PubMed  CAS  Google Scholar 

  7. Parish LC, Witkowski JA, Millikan LE. Scabies in the extended care facility: revisited. Int J Dermatol 1991; 30: 703–6

    Article  PubMed  CAS  Google Scholar 

  8. Konishi N, Suzuki K, Tokura Y, et al. Bullous eruption associated with scabies: evidence for scabetic induction of true bullous pemphigoid. Acta Derm Venereol 2000; 80 (4): 281–3

    Article  PubMed  CAS  Google Scholar 

  9. Hurwitz S. Scabies in babies. Am J Dis Child 1973; 126 (2): 226–8

    PubMed  CAS  Google Scholar 

  10. Parish LC, Millikan LE, Witkowski JA, et al. Scabies in the extended care facility. Int J Dermatol 1983; 22: 380–2

    Article  PubMed  CAS  Google Scholar 

  11. Wendel K, Rompalo A. Scabies and pediculosis pubis: an update of treatment regimens and general review. Clin Infect Dis 2002; 35 Suppl. 2: S146–51

    Article  Google Scholar 

  12. del Giudice P. Ivermectin in scabies. Curr Opin Infect Dis 2002; 15: 123–6

    Article  PubMed  Google Scholar 

  13. Elgart ML. A risk-benefit assessment of agents used in the treatment of scabies. Drug Saf 1996; 14 (6): 386–93

    Article  PubMed  CAS  Google Scholar 

  14. Franz TJ, Lehman PA, Franz SF, et al. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 1996; 132: 901–5

    Article  PubMed  CAS  Google Scholar 

  15. Solomon BA, Haut SR, Carr EM, et al. Neurotoxic reaction to lindane in an HIV-seropositive patient. An old medication’s new problem. J Fam Pract 1995; 40 (3): 291–6

    PubMed  CAS  Google Scholar 

  16. Buffet M, Dupin N. Current treatments for scabies. Fundam Clin Pharmacol 2003; 17 (2): 217–25

    Article  PubMed  CAS  Google Scholar 

  17. Bigby M. A systematic review of the treatment of scabies. Arch Dermatol 2000; 136: 387–9

    Article  PubMed  CAS  Google Scholar 

  18. Millership S, Readman R, Bracebridge S. Use of ivermectin, given orally, to control scabies in homes for the elderly mentally ill. Commun Dis Public Health 2002; 5: 144–6

    PubMed  CAS  Google Scholar 

  19. Haas N, Henz BM, Ohlendorf D. Is a single oral dose of ivermectin sufficient in crusted scabies? Int J Dermatol 2001; 40: 599–600

    Article  PubMed  CAS  Google Scholar 

  20. Elgart GW, Meinking TL. Ivermectin. Dermatol Clin 2003; 21 (2): 277–82

    Article  PubMed  CAS  Google Scholar 

  21. Yonkosky D, Ladia L, Gackenheimer L, et al. Scabies in nursing homes: an eradication program with permethrin 5% cream. J Am Acad Dermatol 1990; 23: 1133–6

    Article  PubMed  CAS  Google Scholar 

  22. Robles Garcia M, de la Lama Lopez-Areal J, Avellaneda Martinez C, et al. Nosocomial scabies outbreak. Rev Clin Esp 2000; 200: 538–42

    PubMed  CAS  Google Scholar 

  23. Wilson MM, Philpott CD, Breer WA. Atypical presentation of scabies among nursing home residents. J Gerontol A Biol Sci Med Sci 2001; 56: M424–7

    Article  Google Scholar 

  24. Dannaoui E, Kiazand A, Piens M, et al. Use of ivermectin for the management of scabies in a nursing home. Eur J Dermatol 1999; 9: 443–5

    PubMed  CAS  Google Scholar 

  25. Sullivan JR, Watt G, Barker B. Successful use of ivermectin in the treatment of endemic scabies in a nursing home. Australas J Dermatol 1997; 38: 137–40

    Article  PubMed  CAS  Google Scholar 

  26. Estes SA, Estes J. Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol 1993; 12: 26–33

    PubMed  CAS  Google Scholar 

  27. Paasch U, Haustein UF. Treatment of endemic scabies with allethrin, permethrin and ivermectin: evaluation of a treatment strategy. Hautarzt 2001; 52 (1): 31–7

    Article  PubMed  CAS  Google Scholar 

  28. Paasch U, Haustein UF. Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. Int J Dermatol 2000; 39: 463–70

    Article  PubMed  CAS  Google Scholar 

  29. Andersen BM, Haugen H, Rasch M, et al. Outbreak of scabies in Norwegian nursing homes and home care patients: control and prevention. J Hosp Infect 2000; 45: 160–4

    Article  PubMed  CAS  Google Scholar 

  30. Xavier G. Public relations. Nurs Times 1998; 94: 74–5

    PubMed  CAS  Google Scholar 

  31. Paules SJ, Levisohn D, Heffron W. Persistent scabies in nursing home patients. J Fam Pract 1993; 37: 82–6

    PubMed  CAS  Google Scholar 

  32. Jack M. Scabies outbreak in an extended care unit: a positive outcome. Can J Infect Control 1993; 8: 11–3

    PubMed  CAS  Google Scholar 

  33. Jimenez-Lucho VE, Fallon F, Caputo C, et al. Role of prolonged surveillance in the eradication of nosocomial scabies in an extended care Veterans Affairs medical center. Am J Infect Control 1995; 23: 44–9

    Article  PubMed  CAS  Google Scholar 

  34. Arlian LG, Estes SA, Vyszenski-Moher DL. Prevalence of Sarcoptes scabiei in the homes and nursing homes of scabietic patients. J Am Acad Dermatol 1988; 19: 806–11

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this manuscript. The author has no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Noah Scheinfeld.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scheinfeld, N. Controlling Scabies in Institutional Settings. Am J Clin Dermatol 5, 31–37 (2004). https://doi.org/10.2165/00128071-200405010-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200405010-00005

Keywords

Navigation